Comparison of the efficacy of solifenacin and duloxetine in the treatment of overactive bladder disease

Phase 2

Recruiting

• Conditions: over active bladder.; other specified disorders of bladder; N32.81

• Registration Number: IRCT20191010045047N1
• Lead Sponsor: Kerman University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 13 January 2020

Recruitment & Eligibility

• Status: Recruiting
• Sex: Female
• Target Recruitment: 60

Inclusion Criteria

All women had urinary frequency more than six times a day at intervals less than one hour

Exclusion Criteria

urinary tract infection
diabetes
under 18 years old
BMI greater than 35
smokers
having bladder stones
previous surgical history

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Patients symptoms of OAB. Timepoint: First of trial and one month later. Method of measurement: International consultation on incontinence questionnaire.;Drug side effects. Timepoint: One month later. Method of measurement: Patient history.